Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gazmend Temaj, Sarmistha Saha, Shpend Dragusha, Valon Ejupi, Brigitta Buttari, Elisabetta Profumo, Lule Beqa & Luciano Saso. (2022) Ribosomopathies and cancer: pharmacological implications. Expert Review of Clinical Pharmacology 15:6, pages 729-746.
Read now
Read now
Zhaohua Xiao, Jing Peng, Liwen Wu, Ahmed Arafat & Fei Yin. (2017) The effect of IL-1β on synaptophysin expression and electrophysiology of hippocampal neurons through the PI3K/Akt/mTOR signaling pathway in a rat model of mesial temporal lobe epilepsy. Neurological Research 39:7, pages 640-648.
Read now
Read now
Fan Yang, Shixu Lyu, Siyang Dong, Yehuan Liu, Xiaohua Zhang & Ouchen Wang. (2016) Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics. OncoTargets and Therapy 9, pages 761-772.
Read now
Read now
Articles from other publishers (30)
Anne Adebukola Adeyanju. 2023. Citrus Research - Horticultural and Human Health Aspects. Citrus Research - Horticultural and Human Health Aspects.
Muhammad Ali, Viviana Benfante, Alessandro Stefano, Anthony Yezzi, Domenico Di Raimondo, Antonino Tuttolomondo & Albert Comelli. (2023) Anti-Arthritic and Anti-Cancer Activities of Polyphenols: A Review of the Most Recent In Vitro Assays. Life 13:2, pages 361.
Crossref
Crossref
Elif Ulu, İlhan Yaylım, Soykan Arıkan & Canan Cacına. (2022)
The evaluation of
PIK3CA
gene variation and serum PI3K level in breast cancer risk and prognosis in Turkish population
. Turkish Journal of Biochemistry 47:3, pages 317-324.
Crossref
Crossref
Youchao Qi, Guozhen Duan, Guanghui Fan & Ning Peng. (2022) Effect of Lycium barbarum polysaccharides on cell signal transduction pathways. Biomedicine & Pharmacotherapy 147, pages 112620.
Crossref
Crossref
Nicholas Turner, Rebecca A. Dent, Joyce O’Shaughnessy, Sung-Bae Kim, Steven J. Isakoff, Carlos Barrios, Shigehira Saji, Igor Bondarenko, Zbigniew Nowecki, Qinshu Lian, Sarah-Jayne Reilly, Heather Hinton, Matthew J. Wongchenko, Bruno Kovic, Aruna Mani & Mafalda Oliveira. (2021) Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial. Breast Cancer Research and Treatment 191:3, pages 565-576.
Crossref
Crossref
Xiaoniu Fang, Ya Gao, Chen Wang, Huimin Chen & Tong Zhu. (2022) Exploring the selective mechanism of inhibitors towards different subtypes of class I PI3K. Chemical Physics Letters 786, pages 139174.
Crossref
Crossref
Daniela Miricescu, Alexandra Totan, Iulia-Ioana Stanescu-Spinu, Silviu Constantin Badoiu, Constantin Stefani & Maria Greabu. (2020) PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects. International Journal of Molecular Sciences 22:1, pages 173.
Crossref
Crossref
Fei Xu, Lixin Na, Yanfei Li & Linjun Chen. (2020) RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell & Bioscience 10:1.
Crossref
Crossref
Milad Ashrafizadeh, Masoud Najafi, Pooyan Makvandi, Ali Zarrabi, Tahereh Farkhondeh & Saeed Samarghandian. (2020) Versatile role of curcumin and its derivatives in lung cancer therapy. Journal of Cellular Physiology 235:12, pages 9241-9268.
Crossref
Crossref
Pengzhan He, Jingjing Ma, Yinghui Liu, Huan Deng & Weiguo Dong. (2020) Hesperetin Promotes Cisplatin−Induced Apoptosis of Gastric Cancer In Vitro and In Vivo by Upregulating PTEN Expression. Frontiers in Pharmacology 11.
Crossref
Crossref
Nne E. Uko, Osman F. Güner, Diane F. Matesic & J. Phillip Bowen. (2020) Akt Pathway Inhibitors. Current Topics in Medicinal Chemistry 20:10, pages 883-900.
Crossref
Crossref
Li Wang, Kunkun Li, Chen Wang, Xiaoxin Shi & Huiyu Yang. (2019) miR‐107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K‐AKT signaling pathway by down‐regulating FAT4. Cancer Medicine 8:11, pages 5264-5273.
Crossref
Crossref
Guixin Yuan, Zhen Lian, Qian Liu, Xixi Lin, Dantao Xie, Fangming Song, Xinjia Wang, Siyuan Shao, Bo Zhou, Chen Li, Muyan Li & Guanfeng Yao. (2019) Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis. Cancer Letters 443, pages 135-144.
Crossref
Crossref
OmniaY Bassouny, RashaM AbdRabh & Ahmed Khalil. (2019) Evaluation of expression of Snail and Her2/neu and their clinicopathological significance in serous ovarian tumors: an immunohistochemical study. Egyptian Journal of Pathology 39:2, pages 419.
Crossref
Crossref
Shuang Zhao, Lisha Wu, Yehong Kuang, Juan Su, Zhongling Luo, Yan Wang, Jinmao Li, Jianglin Zhang, Wangqing Chen, Fangfang Li, Yijing He, Juan Tao, Jianda Zhou, Xiaowei Xu, Cong Peng & Xiang Chen. (2018) Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression. International Journal of Oncology.
Crossref
Crossref
Juan Zhou, Yunfeng Pei, Geng Chen, Chunping Cao, Jia Liu, Chen Ding, Duping Wang, Li Sun, Peng Xu & Guoping Niu. (2018) SPC24 Regulates breast cancer progression by PI3K/AKT signaling. Gene 675, pages 272-277.
Crossref
Crossref
M. Orditura, C.M. Della Corte, A. Diana, V. Ciaramella, E. Franzese, V. Famiglietti, I. Panarese, R. Franco, A. Grimaldi, A. Lombardi, M. Caraglia, A. Santoriello, E. Procaccini, E. Lieto, E. Maiello, F. De Vita, F. Ciardiello & F. Morgillo. (2018) Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs. The Breast 41, pages 165-171.
Crossref
Crossref
Songlin Liu, Yunhong Tang, Maomao Yan & Weixi Jiang. (2018) PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation. Investigational New Drugs 36:5, pages 763-772.
Crossref
Crossref
Shan Hu, Yingchun Xu, Liwei Meng, Liming Huang & He Sun. (2018) Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells. Experimental and Therapeutic Medicine.
Crossref
Crossref
Donatella Delle Cave, Vincenzo Desiderio, Laura Mosca, Concetta P. Ilisso, Luigi Mele, Michele Caraglia, Giovanna Cacciapuoti & Marina Porcelli. (2017) S‐Adenosylmethionine‐mediated apoptosis is potentiated by autophagy inhibition induced by chloroquine in human breast cancer cells. Journal of Cellular Physiology 233:2, pages 1370-1383.
Crossref
Crossref
Floriana Morgillo, Carminia Maria Della Corte, Anna Diana, Concetta di Mauro, Vincenza Ciaramella, Giusi Barra, Valentina Belli, Elisena Franzese, Roberto Bianco, Evaristo Maiello, Ferdinando De Vita, Fortunato Ciardiello & Michele Orditura. (2017) Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells. Oncotarget 8:44, pages 76479-76491.
Crossref
Crossref
Xiao Zhou, Zhen Huang, Huawei Yang, Yi Jiang, Wei Wei, Qiuyun Li, Qinguo Mo & Jianlun Liu. (2017) β-Glucosidase inhibition sensitizes breast cancer to chemotherapy. Biomedicine & Pharmacotherapy 91, pages 504-509.
Crossref
Crossref
Yi Wei Hu, Xiao Man Wu, Shi Si Ren, Lu Cao, Pin Nie & Ming Xian Chang. (2017) NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway. Scientific Reports 7:1.
Crossref
Crossref
Yu-Fu Zhou, Qian Sun, Ya-Jun Zhang, Geng-Ming Wang, Bin He, Tao Qi, Yan Zhou, Xing-Wang Li, Sheng Li & Lin He. (2017) Targeted inhibition of Notch1 gene enhances the killing effects of paclitaxel on triple negative breast cancer cells. Asian Pacific Journal of Tropical Medicine 10:2, pages 179-183.
Crossref
Crossref
Ingeborg Elisabeth Cernaj. (2016) Simultaneous dual targeting of Par-4 and G6PD: a promising new approach in cancer therapy? Quintessence of a literature review on survival requirements of tumor cells. Cancer Cell International 16:1.
Crossref
Crossref
Yingying Liu, Shanshan Fang, Qiushi Sun & Bo Liu. (2016) Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress. Biochemical and Biophysical Research Communications 480:3, pages 415-421.
Crossref
Crossref
Min Yu, Ruishu Li & Juan Zhang. (2016) Repositioning of antibiotic levofloxacin as a mitochondrial biogenesis inhibitor to target breast cancer. Biochemical and Biophysical Research Communications 471:4, pages 639-645.
Crossref
Crossref
Joelle ZambranoElizabeth S. Yeh. (2016) Autophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast Cancer. Breast Cancer: Basic and Clinical Research 10, pages BCBCR.S32791.
Crossref
Crossref
Lu Guo, Hua Wu, Jinghong Zhu, Caixia Zhang, Jianxiu Ma, Jianfa Lan & Xiaodong Xie. (2015) Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer. Life Sciences 143, pages 217-224.
Crossref
Crossref
Antonio Gentilella, Sara C. Kozma & George Thomas. (2015) A liaison between mTOR signaling, ribosome biogenesis and cancer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1849:7, pages 812-820.
Crossref
Crossref